W. Qian

发表

Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients

Libin Zhou, Guoyue Yuan, Hao Hu, 2014, Diabetes Care.

Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide: A Randomized, Controlled, Crossover Trial

J. Haight, C. Kendall, K. Lapsley, 2002, Circulation.

Significant association of insulin and proinsulin with clustering of cardiovascular risk factors.

Zhijian Yang, Shi-wei Chen, En-Zhi Jia, 2005, World journal of gastroenterology.

Reduced circulating oxytocin and High-Molecular-Weight adiponectin are risk factors for metabolic syndrome.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.

Apolipoprotein E polymorphism in the early onset of coronary heart disease.

K. Cao, W. Qian, T. Zhu, 2001, Chinese medical journal.

Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2014, Endocrine journal.

Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.

Libin Zhou, Dezhi Chen, Guoyue Yuan, 2015, Endocrine journal.

Level of proinsulin in association with cardiovascular risk factors and sleep snoring.

Zhijian Yang, Shi-wei Chen, En-Zhi Jia, 2005, World journal of gastroenterology.

Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2014, The Journal of clinical endocrinology and metabolism.

Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.

Effect of glucagon‐like peptide‐1 receptor agonists in subjects with type 2 diabetes mellitus: A meta‐analysis

W. Qian, Qichao Yang, Fei Liu, 2021, Journal of clinical pharmacy and therapeutics.

Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.